STOCKHOLM, SWEDEN – 20 April 2021.
The shareholders of Modus Therapeutics Holding AB, 556851-9523, are hereby invited to attend the Annual General Meeting on Monday, May 3rd 2021. Due to the ongoing pandemic, the Annual General Meeting, with the support of temporary legal rules, will be conducted through postal vote in advance only (postal vote). No Annual General Meeting with the opportunity to attend in person or by proxy will take place. Information on the resolutions passed by the Annual General Meeting will be published on May 3rd 2021 as soon as the outcome of the postal voting has been finally compiled.
For more details, please follow the following documents: